Placebo n = 73 | TRF n = 73 | p value | |
---|---|---|---|
Age in years (mean, SD) | 9.4 (1.7) | 9.4 (1.9) | 0.854 |
Male: Female ratio | 61 male: 12 female | 63 male: 10 female | 0.644 |
Education Type (n) | |||
Mainstream | 58 | 56 | 0.689 |
Special education | 13 | 15 | |
Others | 2 | 2 | |
Parental Education (n) | |||
None/Primary | 7 | 9 | 0.866 |
Secondary | 46 | 45 | |
Tertiary | 20 | 19 | |
ADHD subtypes (n) | |||
Inattentive | 9 | 8 | 0.796 |
Combined | 64 | 65 | |
Presence of comorbid conditions (n) | 30 | 26 | 0.496 |
Medication for ADHD (n) | 35 | 43 | 0.184 |
Mean Baseline VAPRS total symptom score (SD) | 28.97 (9.37) | 28.91 (10.37) | 0.976 |
Mean Baseline VATRS total symptom score (SD)a | 25.83 (10.35)a | 25.40 (10.55)a | 0.844 |
Baseline tocotrienol levels (Median) | |||
Delta (ng/ml) | 9.900 | 10.050 | 0.967 |
Gamma (ng/ml) | 43.30 | 48.40 | 0.709 |
Alpha (ng/ml) | 24.60 | 26.40 | 0.935 |